U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07410169) titled 'Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral Neuropathy' on Jan. 27.
Brief Summary: The goal of this research is to assess whether hyperbaric oxygen therapy can alleviate the symptoms of Nab-paclitaxel-induced peripheral neuropathy and improve patient-reported quality of life.
Study Start Date: Jan. 31
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
CIPN - Chemotherapy-Induced Peripheral Neuropathy
Paclitaxel-induced Peripheral Neuropathy
Intervention:
DEVICE: Hyperbaric oxygen treatment
Patients who meet the inclusion criteria will be enrolled and given hyperbaric oxygen...